“Chris is VERY good, and delivers ´consistantly and with high quality outcomes on time.”
Cambridge, Massachusetts, United States
Contact Info
3K followers
500+ connections
Activity
-
Very happy to share the news of Jnana's acquisition by Otsuka. It has been such an incredible team effort to bring Jnana to this exciting next stage!…
Very happy to share the news of Jnana's acquisition by Otsuka. It has been such an incredible team effort to bring Jnana to this exciting next stage!…
Liked by Chris Vlahos
-
Very proud of the many great professionals who worked tirelessly to bring this important innovative therapy one step closer to patients with PKU!
Very proud of the many great professionals who worked tirelessly to bring this important innovative therapy one step closer to patients with PKU!
Liked by Chris Vlahos
-
I’m thrilled to announce that I’m joining Rectify. Together, we’ll explore innovative approaches to treating diseases linked to ABC transporter…
I’m thrilled to announce that I’m joining Rectify. Together, we’ll explore innovative approaches to treating diseases linked to ABC transporter…
Liked by Chris Vlahos
Experience & Education
Honors & Awards
-
Fellow
American Heart Association, Council on Atherosclerosis, Thrombosis, and Vascular Biology
Recommendations received
1 person has recommended Chris
Join now to viewMore activity by Chris
-
Delighted to be part of a dedicated team that worked towards securing EX-US Licensing rights of Tovorafenib for treatment of pediatric low grade…
Delighted to be part of a dedicated team that worked towards securing EX-US Licensing rights of Tovorafenib for treatment of pediatric low grade…
Liked by Chris Vlahos
-
📄 #PressRelease GENFIT: Positive Opinion from EMA Committee for Ipsen’s Iqirvo® (elafibranor) in Primary Biliary Cholangitis 👉…
📄 #PressRelease GENFIT: Positive Opinion from EMA Committee for Ipsen’s Iqirvo® (elafibranor) in Primary Biliary Cholangitis 👉…
Liked by Chris Vlahos
-
Delighted to announce our new partnership with Day One Pharmaceuticals. We are looking forward to accelerating the delivery of this innovation to…
Delighted to announce our new partnership with Day One Pharmaceuticals. We are looking forward to accelerating the delivery of this innovation to…
Liked by Chris Vlahos
-
My first cycle of interviews at Lilly ended in disaster. After 2 full days of interviews, I received a phone call sharing that I would not be…
My first cycle of interviews at Lilly ended in disaster. After 2 full days of interviews, I received a phone call sharing that I would not be…
Liked by Chris Vlahos
-
Pharma Partnering Summit is delighted to introduce Masha Kurbatova, Senior Director, Global Partnering Oncology at Ipsen as a Panelist at Pharma…
Pharma Partnering Summit is delighted to introduce Masha Kurbatova, Senior Director, Global Partnering Oncology at Ipsen as a Panelist at Pharma…
Liked by Chris Vlahos
-
We're thrilled to announce a $122M Series A financing, led by The Column Group with participation from a select group of investors. Read press…
We're thrilled to announce a $122M Series A financing, led by The Column Group with participation from a select group of investors. Read press…
Liked by Chris Vlahos
-
Congratulations to HuntX for winning Ipsen Golden Ticket and very proud to have been part of this jury #ipsen #goldenticket #neurosciences…
Congratulations to HuntX for winning Ipsen Golden Ticket and very proud to have been part of this jury #ipsen #goldenticket #neurosciences…
Liked by Chris Vlahos
-
Today we announced positive 24-week data from our Phase 2a INTEGRIS-PSC trial in patients with primary sclerosing cholangitis. Learn more about these…
Today we announced positive 24-week data from our Phase 2a INTEGRIS-PSC trial in patients with primary sclerosing cholangitis. Learn more about these…
Liked by Chris Vlahos
-
Milestone achieved! After 30 years in California, I finally took the oath and became ... a citizen of the United States of America. It is (perhaps…
Milestone achieved! After 30 years in California, I finally took the oath and became ... a citizen of the United States of America. It is (perhaps…
Liked by Chris Vlahos
-
We are excited to announce the appointment of Alastair Garfield, Ph.D., as Chief Scientific Officer of Rhythm Pharmaceuticals!…
We are excited to announce the appointment of Alastair Garfield, Ph.D., as Chief Scientific Officer of Rhythm Pharmaceuticals!…
Liked by Chris Vlahos
-
Grateful to Rutgers Fellows for giving me amazing opportunities to learn, grow and network!!
Grateful to Rutgers Fellows for giving me amazing opportunities to learn, grow and network!!
Liked by Chris Vlahos
Other similar profiles
-
Lori Badura
Connect -
Masha Kurbatova
Connect -
David Loew
Connect -
Clément Gautier
Connect -
Nick Gagnon
Vice President, Head of Oncology Global Partnering at Ipsen
Connect -
Madee Gooriah PharmD, MS
Connect -
Nader Yaghoubi, M.D., Ph.D.
Connect -
Kalyan Chakravarthy
Connect -
Fabrice Bocquillon
Connect -
Christopher Hupp
Connect
Explore collaborative articles
We’re unlocking community knowledge in a new way. Experts add insights directly into each article, started with the help of AI.
Explore MoreOthers named Chris Vlahos in United States
-
Chris Vlahos
Project Management | Program Management | Agile | Product Owner | Organizational Development & Leadership | Experienced Leader | Cross-Functional Collaborator
-
Chris Vlahos
-
Chris Vlahos
Litigation Assistant, Certificated Paralegal (UCLA), TV & Radio Anchor/ Reporter/ Producer/ Journalist
-
Chris Vlahos
Owner Barefoot Bernie's Tropical Grill & Bar
21 others named Chris Vlahos in United States are on LinkedIn
See others named Chris Vlahos